Evidence map›Paper›PMID 40366868›Full record

ArticleGigaScience2025

Spatial integration of multi-omics data from serial sections using the novel Multi-Omics Imaging Integration Toolset.

Maximilian Wess, Maria K Andersen, Elise Midtbust, Juan Carlos Cabellos Guillem, Trond Viset, Øystein Størkersen, Sebastian Krossa, Morten Beck Rye, May-Britt Tessem

Abstract read
In one paragraph

Article in GigaScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Mapping multipathology via spatial omic integration.Current opinion in biotechnology · 2026
    Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Maximilian WessDepartment of Circulation and Medical Imaging, NTNU-Norwegian University of Science and Technology, Trondheim, 7491, Norway.ORCID 0009-0002-4227-6569
Maria K AndersenDepartment of Circulation and Medical Imaging, NTNU-Norwegian University of Science and Technology, Trondheim, 7491, Norway.ORCID 0000-0003-2883-2450
Elise MidtbustDepartment of Circulation and Medical Imaging, NTNU-Norwegian University of Science and Technology, Trondheim, 7491, Norway.ORCID 0009-0001-2794-7080
Juan Carlos Cabellos GuillemDepartment of Circulation and Medical Imaging, NTNU-Norwegian University of Science and Technology, Trondheim, 7491, Norway.ORCID 0009-0004-0613-2378
Trond VisetDepartment of Pathology, St. Olavs Hospital, Trondheim University Hospital, Trondheim, 7030, Norway.
Øystein StørkersenDepartment of Pathology, St. Olavs Hospital, Trondheim University Hospital, Trondheim, 7030, Norway.
Sebastian KrossaDepartment of Circulation and Medical Imaging, NTNU-Norwegian University of Science and Technology, Trondheim, 7491, Norway.ORCID 0000-0002-1959-0130
Morten Beck RyeELIXIR, Norway.ORCID 0000-0002-4405-1008
May-Britt TessemDepartment of Circulation and Medical Imaging, NTNU-Norwegian University of Science and Technology, Trondheim, 7491, Norway.ORCID 0000-0001-5734-2157

Funding

Central Norway Regional Health Authority 26094European Research CouncilHorizon 2020 758306Norwegian Cancer Society 208263-2019Norwegian Cancer Society 322392Norwegian University of Science and TechnologyResearch Council of Norway 248810
6 · The paper itself

Abstract

backgroundTruly understanding the cancer biology of heterogeneous tumors in precision medicine requires capturing the complexities of multiple omics levels and the spatial heterogeneity of cancer tissue. Techniques like mass spectrometry imaging (MSI) and spatial transcriptomics (ST) achieve this by spatially detecting metabolites and RNA but are often applied to serial sections. To fully leverage the advantage of such multi-omics data, the individual measurements need to be integrated into 1 dataset.

resultsWe present the Multi-Omics Imaging Integration Toolset (MIIT), a Python framework for integrating spatially resolved multi-omics data. A key component of MIIT's integration is the registration of serial sections for which we developed a nonrigid registration algorithm, GreedyFHist. We validated GreedyFHist on 244 images from fresh-frozen serial sections, achieving state-of-the-art performance. As a proof of concept, we used MIIT to integrate ST and MSI data from prostate tissue samples and assessed the correlation of a gene signature for citrate-spermine secretion derived from ST with metabolic measurements from MSI.

conclusionMIIT is a highly accurate, customizable, open-source framework for integrating spatial omics technologies performed on different serial sections.

Indexed as

Computational BiologyGenomicsMetabolomicsSoftwareAlgorithmsGene Expression ProfilingHumansImage Processing, Computer-AssistedMaleMass SpectrometryMultiomicsProstatic NeoplasmsTranscriptomeimage registrationmass spectrometry imagingspatial transcriptomics

Identifiers

PMID40366868
PMCPMC12077394

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.